Abstract

Aim: To highlight the challenge in the management of Arginosuccinic acidemia as well as demonstrate the importance of newborn screening for inborn errors of metabolism. Method: Report of two cases of neonatal onset ASA with encephalopathy and review of relevant literature. Conclusion: Early diagnosis and institution of appropriate intervention can significantly improve outcome. Routine newborn metabolic screening should not only be implemented universally, the result should be available promptly.

Highlights

  • Argininosuccinic acidemia (ASA) known as Argininosuccinate lyase deficiency is an inborn error of metabolism affecting the urea cycle

  • ASA is caused by mutations in the ASL gene (7q11.21) that encodes the enzyme argininosuccinate lyase

  • We present a nine day old male late preterm neonate admitted to the neonatal intensive care unit (NICU) with a two day history of reduced activity and poor suck

Read more

Summary

Introduction

Argininosuccinic acidemia (ASA) known as Argininosuccinate lyase deficiency is an inborn error of metabolism affecting the urea cycle. ASA is caused by mutations in the ASL gene (7q11.21) that encodes the enzyme argininosuccinate lyase This enzyme catalyzes the conversion of argininosuccinic acid into arginine and fumarate during the fourth step of the urea cycle. Defects in this step of the urea cycle lead to an accumulation of plasma ammonia, argininosuccinic acid, citrulline, and urinary orotic acid, and to a plasma arginine deficiency [1,2,3]. Clinical findings are usually non-specific and similar to those seen in infants with other inborn errors of metabolism or infections

Objectives
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.